Skip to main content

$0.150 -0.005 (-3.23%)

High

$0.16

Low

$0.15

Trades

36

Turnover

$273,289

Volume

1,784,638
30 June 2023 at 3:31pm
Register to track EIQ and receive email alerts.

Positive Interim Results From Clinical Trial at St Vincent's

StockBot

416,823 posts

EIQ released this announcement to the ASX on 15 December 2022, 8:48. The announcement is marked as price sensitive, and is 2 page(s) in length and 72.4kb in size.

You can view all announcements from EIQ and see how they appear on a price chart on the announcements page.

At the date of this announcement, EIQ was 0.006% short sold according to ASIC data. It was ranked the 588th most shorted stock on the ASX. It is now ranked as the 432nd most shorted stock on the ASX with 0.084% of total shares short sold as of the latest reported data (13 May 2025).

Other Recent Announcements from EIQ
Cleansing Notice 28 June 2023, 8:18
Application for quotation of securities - EIQ 27 June 2023, 19:29
ECHO IQ SECURES MAIDEN AUSTRALIAN HOSPITAL SALE OF ECHOSOLV 22 June 2023, 8:20
Positive Interim Results From Clinical Trial at St Vincent's 15 December 2022, 8:48
Change of Director's Interest Notice - S Picton 9 December 2022, 13:53
Change of Director's Interest Notice - S Formica 9 December 2022, 13:50
Change of Director's Interest Notice - A Grover 9 December 2022, 13:43
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EIQ and receive email alerts.